293 related articles for article (PubMed ID: 21563230)
21. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
22. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
23. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
[TBL] [Abstract][Full Text] [Related]
24. Differentially expressed microRNAs in small cell lung cancer.
Miko E; Czimmerer Z; Csánky E; Boros G; Buslig J; Dezso B; Scholtz B
Exp Lung Res; 2009 Oct; 35(8):646-64. PubMed ID: 19895320
[TBL] [Abstract][Full Text] [Related]
25. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
28. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
29. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
30. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
32. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
[TBL] [Abstract][Full Text] [Related]
37. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
38. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA expression profiles of porcine skeletal muscle.
Zhou B; Liu HL; Shi FX; Wang JY
Anim Genet; 2010 Oct; 41(5):499-508. PubMed ID: 20331612
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis.
Navarro A; Marrades RM; Viñolas N; Quera A; Agustí C; Huerta A; Ramirez J; Torres A; Monzo M
Oncology; 2009; 76(3):162-9. PubMed ID: 19209007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
